Solid Biosciences (SLDB) Revenue (2021 - 2022)
Solid Biosciences' Revenue was $8.09 million in FY2022, down 40.6% from $13.62 million in FY2021.
Powered by 
Analysis
Solid Biosciences (SLDB) Revenue (2021 - 2022) Analysis & Trends
- Per Business Quant data, Revenue in earlier years was $13.62 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Solid Biosciences | 889.43 Mn | -292.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 6.17 Mn |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | -14,000.00 |
API Access
Solid Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();